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Keratin K6c Mutations Cause Focal Palmoplantar
Keratoderma
Neil J. Wilson1,2, Andrew G. Messenger3, Sancy A. Leachman4, Edel A. O’Toole5, E. Birgitte Lane2,6,
W.H. Irwin McLean1 and Frances J.D. Smith1
The palmoplantar keratodermas (PPKs) are a large group of clinically and genetically heterogeneous
genodermatoses. The gene defects underlying many PPKs still need to be resolved to facilitate definitive
molecular diagnosis and genetic counseling. Dominant-negative mutations in any of the four identified keratin
genes, KRT6A, KRT6B, KRT16, or KRT17, cause pachyonychia congenita (PC), characterized by hypertrophic nail
dystrophy and other ectodermal features. In PC, focal PPK (FPPK) is the most painful and debilitating phenotypic
feature. Some families presenting with FPPK alone, or with minimal nail changes, carry mutations in KRT16;
however, most FPPK families do not harbor mutations in any of these keratin genes. Here, we report three
unrelated families who presented with familial FPPK with minor or absent nail changes. The four PC/FPPK-
related keratin genes were excluded; however, mutational analysis of the recently identified KRT6C gene,
encoding keratin K6c, showed heterozygous in-frame deletion mutations in all three kindreds. Affected
members of Families 1 and 2 carried the same mutation, p.Asn172del. In Family 3, the mutation p.Ile462-
Glu470del co-segregated with the disease. KRT6C was shown to be expressed in the plantar epidermis using
reverse transcription-PCR, consistent with the phenotype observed in this tissue. These data expand the genetic
testing repertoire for the PPKs.
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INTRODUCTION
The palmoplantar epidermis is a histologically and devel-
opmentally distinct region of the epidermis that is highly
specialized to resist the high degree of mechanical trauma to
which this tissue is subjected during everyday life (Swensson
et al., 1998). To this end, the palmoplantar epidermis expresses
a very large number of structural reinforcement molecules
including many keratins and associated proteins (McLean,
2003). The palmoplantar keratodermas (PPKs) are a large group
of genodermatoses characterized by keratinocyte fragility,
blistering, and thickening (hyperkeratosis) within the palmo-
plantar epidermis (Judge et al., 2004; Itin and Fistarol, 2005).
The OMIM clinical genetics database lists 59 distinct disorders
that include PPK as a part of the phenotype, and there are a
number of forms of PPK recognized by dermatologists that do
readily fall into these categories (Stevens et al., 1996; Judge
et al., 2004). The major subdivisions of the PPKs are diffuse,
focal (including striate), and punctate, according to the pattern
of hyperkeratotic lesions observed clinically.
Focal PPK (FPPK) is one of the cardinal features of
pachyonychia congenita (PC; OMIM #167200, #167210), a
rare autosomal-dominant keratin disorder caused by muta-
tions in the differentiation-specific keratin genes KRT6A
(Bowden et al., 1995), KRT6B (Smith et al., 1998), KRT16,
or KRT17 (McLean et al., 1995; Liao et al., 2007). Blisters
occur under the hyperkeratotic lesions on the plantar
surfaces, which are often extremely painful, resulting in
restricted mobility (Leachman et al., 2005). Palmar lesions
are less prominent and tend to occur in response to
occupational mechanical trauma. Other clinical character-
istics of PC include hypertrophic nail dystrophy and other
ectodermal features (Leachman et al., 2005). FPPK can also
present as a separate clinical entity with subtle or absent nail
changes and, interestingly, mutations in KRT16 have also
been reported in some of these families (Shamsher et al.,
1995; Smith et al., 2000, 2005; Liao et al., 2007). This
condition has been described previously as non-epidermoly-
tic PPK (OMIM #600962); however, histological and ultra-
structural evidence of epidermolysis has been reported in at
least some patients with KRT16 mutations (McLean et al.,
1995; Liao et al., 2007); hence, this diagnostic distinction is
somewhat ambiguous. In many FPPK families, no mutations
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can be detected in any of the four PC-related keratins
(F.J.D. Smith and W.H.I. McLean, unpublished observations).
There are at least 54 functional keratin genes expressed in
a tissue- and differentiation-specific manner that have a
major structural role in the epidermis and its appendages
(Schweizer et al., 2006). Earlier, the existence of as many as
six copies of nearly identical KRT6 genes have been proposed
in the human genome (Takahashi et al., 1995). However,
with the availability of finished genome sequence for the type
II keratin gene cluster on chromosome 12q13.13, it was
shown that there are only three tandemly repeated epidermal
K6 isogenes, KRT6A, KRT6B, and KRT6C, encoding the
proteins K6a, K6b, and K6c, respectively (Rogers et al., 2005).
The naming of these genes and proteins has recently been
agreed by a nomenclature group representing the keratin field
(Schweizer et al., 2006). The previously reported epidermal
K6-like genes are now believed to be polymorphic variants or
more distantly related type II keratins of the hair follicle. The
coding sequence of all the three authentic epidermal K6
isogenes is very similar, and there is a high degree of overlap
in the tissue expression pattern of K6a and K6b but with some
distinct differences (Smith et al., 1998). There are no reports
on the tissue expression range of K6c, and as the amino-acid
sequence of all the three K6 proteins is almost identical, it has
not been possible to generate isoform-specific antibodies. As
even the upstream promoter regions of these duplicate genes
are highly homologous, we predicted there might be some
degree of overlap in the expression pattern of K6c with K6a
and/or K6b, in which case KRT6C might also be a candidate
gene for FPPK. Here, we present a study of three families with
autosomal-dominant FPPK with very minor or absent nail
changes for which we have identified heterozygous in-frame
deletion mutations in the K6c gene.
RESULTS
Clinical features of focal keratoderma in three families
In Family 1, there were two individuals affected by plantar
FPPK in two generations with male-to-male transmission,
suggestive of autosomal-dominant inheritance. Neither pa-
tient had nail changes (Figures 1 and 2). Plantar blistering was
a feature in both cases and a diagnosis of epidermolysis
bullosa simplex was originally considered. In Family 2, there
were six individuals affected by FPPK in four generations,
again with autosomal-dominant inheritance (Figures 1 and 2).
Affected persons had minor nail changes, specifically nail
hypertrophy affecting only the fifth toe, but this did not
resemble the classic presentation of PC and no other
ectodermal findings consistent with PC were identified. In
Family 3, there were nine affected individuals with FPPK
(Supplementary Figure S1). The proband experienced blister-
ing in the summer months alleviated by low-dose acitretin.
She had subtle leukokeratosis along the buccal bite line and
occasional nail splinter hemorrhages. Autosomal-dominant
transmission was also evident in Family 3 (Figure 1).
K6c helix 1A defect in two unrelated FPPK families
Microsatellite markers within the type I keratin loci on
chromosome 17 excluded the KRT16 and KRT17 genes in
Families 2 and 3; however, markers within the type II keratin
locus on chromosome 12 were consistent with linkage,
suggesting the K6 genes as candidates (data not shown).
Family 1 was too small for informative linkage analysis.
Sequencing of all coding regions and splice sites of the
KRT6A and KRT6B genes did not show any potentially
pathogenic mutations in the three families. Reverse tran-
scriptase-PCR with intron-spanning primers specific for the
KRT6C transcript showed that this gene, similar to KRT6A and
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Figure 1. Pedigrees of Families 1–3 showing autosomal-dominant
inheritance with male-to-male transmission evident in Families 1 and 3.
Asterisk indicates the individuals whose DNA was studied here.
Figure 2. Clinical features. (a and b) FPPK on the soles of the feet of the
proband from Family 1. (c and d) Minor nail changes and (d) FPPK on the
soles of the feet of two affected individuals in Family 2. The clinical features of
Family 3 are shown in Supplementary Figure S1.
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KRT6B, is expressed in mRNA derived from the plantar
epidermis (Supplementary Figure S2), suggesting that this
might be an appropriate candidate gene for FPPK. Consistent
with this hypothesis, mutational analysis of the KRT6C gene,
encoding keratin K6c, showed mutations in all three families.
Specifically, all affected members of Families 1 and 2 carried
a heterozygous 3-bp deletion mutation (Figure 3), designated
p.Asn172del (c.516_518delCAA), within the conserved
N-terminal end of the helix 1A domain of the K6c polypeptide.
The protein sequence motif is one of the two, at either ends of
the keratin rod domain, known to be functionally critical in
mediating molecular overlap interactions during the inter-
mediate filament assembly (Steinert et al., 1993; Herrmann
et al., 2000; Strelkov et al., 2001). The mutation was absent
in the unaffected members of both kindreds and, therefore,
fully co-segregated with FPPK in these unrelated families.
Owing to the high homology of the three K6 genes, the
mutation was independently confirmed in a second, smaller
PCR fragment spanning exon 1 using an alternative set of
primers designed to be specific for KRT6C. A fluorescently
labeled version of this short PCR was used to screen
anonymous population control DNA samples to confirm the
mutation. Interestingly, 3 of 335 population controls were
found to be heterozygous carriers of the mutation p.Asn172-
del mutation, which was confirmed by sequencing. We
speculate that this K6c mutation may exist at a low level
within the general population, but that the relatively mild
plantar callus formation associated with this mutation does
not always come to clinical attention. The ethical approval
framework covering the use of our anonymous population
control series did not allow for retrospective clinical
evaluation of these mutation carriers.
K6c helix 2B deletion in a third FPPK family
DNA sequencing of the KRT6C gene from the proband of the
third family showed an in-frame heterozygous 27-bp deletion
mutation within the 2B domain of K6c protein (Figure 3),
designated as p.Ile462-Glu470del (c.1384-1410del27). This
mutation causes an in-frame deletion of nine amino acids,
leading to the loss of most of the highly conserved helix
termination motif from the helix 2B domain of the K6c
protein—a sequence known to be critically important for the
keratin intermediate filament assembly. The mutation was
confirmed by cloning a PCR fragment spanning exon 7;
sequences from both normal and mutant clones were
obtained. To exclude this mutation as a polymorphism,
354 population control samples as well as 2 unaffected and
6 affected family members were screened by either sequen-
cing or analyzing small PCR fragments spanning exon 7 on
high-resolution 3% agarose gels. Only the six affected
individuals from Family 3 carried the deletion mutation,
K6c p.Ile462-Glu470del.
DISCUSSION
In summary, we report the first mutations to be discovered in
the third human K6 gene, KRT6C, in cases presenting with
PPK and very minor or absent nail changes. The affected
individuals in all three families have relatively mild, site-
restricted keratoderma compared with the much more severe
form seen in many cases of the related condition PC
(Leachman et al., 2005), although the affected family
members, nevertheless, all experience a significant amount
of pain and discomfort from their plantar keratoderma,
requiring secondary medical care.
The p.Asn172del mutation is located within the helix
initiation motif domain of K6c, a region well recognized in
other keratins to be a ‘hotspot’ for pathological mutations
(Szeverenyi et al., 2008), as shown by the data collected
within the Intermediate Filament Database. The analogous
mutation to K6c p.Asn172-del has been reported in both
KRT6A (Bowden et al., 1995; Liao et al., 2007) and KRT6B
(Sharma and Stein, 2007) in cases presenting with typical PC
and in patients with both severe FPPK and severe nail
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Figure 3. Mutational analysis of KRT6C in FPPK families. (a) DNA sequence
of exon 1 of KRT6C derived from a normal control individual, showing
codons 170–176. (b) The equivalent region shown in panel a from an affected
individual in Family 2 showing the deletion mutation p.Asn172del
(c.516_518delCAA). (c) DNA sequence of exon 7 of KRT6C derived from a
normal control individual, showing codons 460–473. (d) Analogous region of
KRT6C as shown in panel c derived from the proband in Family 3, showing a
27-bp, p.Ile462-Glu470del (c.1384-1410del27). (e) KRT6C exon 7 sequence
from a clone derived from a PCR product from the proband in Family 3 to
confirm the extent of the mutation p.Ile462-Glu470del. Arrows indicate
position of mutation.
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dystrophy. Similarly, the equivalent mutation has been seen
in another type II keratin gene, KRT4, in patients with white
sponge nevus, an autosomal-dominant disorder of the
mucosal epithelia (Rugg et al., 1995).
We previously reported a large deletion mutation in
KRT16 in a family also presenting with PPK, in which most of
the helix termination motif of the K16 protein was deleted
(Smith et al., 2000), which is very similar to the genetic lesion
identified here in Family 3 involving K6c. One possible
explanation for the milder phenotype observed in these cases
is that mutant keratin lacking the highly conserved termina-
tion motif would be less able to interact in critical stages of
the keratin filament assembly, and thus might be more likely
to be excluded from the assembly process altogether (Steinert
et al., 1993; Herrmann et al., 2000). This could result in a
milder dominant-negative effect than that of a mutant keratin
that carries a missense or a small deletion mutation within
one of the highly conserved termination domains.
An alternative explanation for the milder phenotype in the
FPPK families with mutations in KRT6C compared with those
with mutations in KRT6A and KRT6B is that K6c may have a
more restricted expression pattern. Although the number of
cases studied is still too small to draw any real conclusions,
this is perhaps the most likely explanation as the equivalent
Asn172del mutation in KRT6A is the most common cause of
the more severe PC/FPPK phenotype (Smith et al., 1999;
Terrinoni et al., 2001; McLean et al., 2005; Liao et al., 2007).
To date, little is known about the expression pattern of K6c
and expression studies have been hampered by the inability
to prepare K6 isoform-specific antibodies. The phenotype
observed in our three families strongly implies overlap with
KRT6A and KRT6B gene expression. The milder phenotype in
the FPPK families with mutations in KRT6C, plus the fact that
some individuals in the general population carry one of these
mutations, p.Asn172del, implies that K6c is expressed at
much lower levels in thick skin and nail than K6a and K6b.
Thus, these KRT6C mutations may be a common genetic
predisposing factor for the plantar callus formation. This
could be addressed by future prospective studies of large
populations that have been examined by dermatologists. In
any case, the identification of K6c mutations expands the
genetics of keratoderma and sheds light on the function of the
keratin gene family, 22 of which are now associated with
human epithelial disorders.
MATERIALS AND METHODS
Genetic linkage analysis
Microsatellite markers D17S800, D17S1861, D17S1868, and KRT12
(Corden et al., 2000) within the type I keratin locus on chromosome
17 and the marker D12S368 within the type II keratin locus on
chromosome 12 were used. Fluorescently labeled PCR fragments
were genotyped by sizing on an ABI 3100 automated DNA
sequencer (Foster City, CA). All PCRs were carried out according
to the manufacturer’s protocol for the ABI PRISM Linkage Mapping
Set-HD5 (Foster City, CA). The study was carried out in accordance
with the Declaration of Helsinki Principles and approved by local
Research Ethics Committees. All subjects or the subjects’ guardians
gave written informed consent.
KRT6C-specific reverse transcriptase-PCR
mRNA was extracted from the plantar skin using the QuickPrep
Micro mRNA Purification Kit (GE Healthcare UK Ltd., Little
Chalfont, Bucks, UK) and reverse transcribed using AMV reverse
transcriptase (Promega, Southampton, UK). cDNA was amplified
using primers KRT6C-4F (forward: 50-CAGCCTCCAACGCTCGC
CA-30) and KRT6C-2149R (reverse: 50-GGGCGGGGGTTCACAA
TACT-30) using Expand High Fidelity PCR buffer (Roche Diagnostics
Ltd., Burgess Hill, UK) containing 1.5mM of MgCl2, 4% DMSO,
and 1U of Expand High Fidelity Enzyme mix (Roche). The following
PCR conditions were used: 94 1C for 5minutes  1, followed by
94 1C for 30 seconds, 54 1C for 1.5minutes, and 72 1C for 3minutes
 35 and 72 1C for 5minutes  1. This PCR amplifies a 2,165-bp
fragment.
Specific full-length genomic KRT6C PCR
Primers KRT6C-FLF1 (forward: 50-ATGGCTGGGGAATGGCTTT
AG-30) and KRT6C-FLR1 (reverse: 50-GGGGCGGGGGTTCACAA
TACT-30) were used with PCR buffer containing 2.5mM of MgCl2 and
Takara (Lonza Biologics PLC, Slough, UK) LA Taq polymerase. The
following PCR conditions were used: 94 1C for 1minute  1,
followed by 98 1C for 5 seconds and 68 1C for 15minutes  30
and 72 1C for 10minutes  1. The resultant 7,034 bp PCR products
were purified using QiaQuick PCR spin columns (Qiagen
House, Craloley, UK) or ExoSAP (using Exonuclease 1 and Shrimp
Antarctic Phosphatase) and sequenced using internal primers on an
ABI 3100 Automated DNA sequencer. The presence of several
diagnostic sequence variations confirmed that this set of primers and
conditions is specific for KRT6C gene and does not amplify KRT6A
or KRT6B.
Specific KRT6C exon 1 PCR
Primers KRT6C-1L (forward: 50-CCAGCCTCCAACGCTCGCCA-30)
and KRT6C-1R (reverse: 50-AGGGCATGGCACTGGCTCAC-30) were
used in GeneAmp PCR Buffer (Applied Biosystems, Foster City, CA)
containing 1.5mM of MgCl2, 4% DMSO, and 1U AmpliTaq Gold
(Applied Biosystems). The following PCR conditions were used:
94 1C for 12minutes  1, followed by 94 1C for 30 seconds, 58 1C for
45 seconds, and 72 1C for 1minute  30, and 72 1C for 5minutes
 1. The resultant fragment was 603 bp. Population control samples
were screened by DNA sequencing, using the above PCRs, or by
fluorescent PCR using modified KRT6C exon 1 primers. The forward
primer was labeled with 6-FAM, and the ‘GTTTCTT’ sequence was
added to 50-end of the reverse primer to improve adenylation of 30
end of PCR product. PCR conditions were as mentioned above,
products were diluted and analyzed on an ABI 3100 Automated
DNA Sequencer.
Specific KRT6C exon 7 PCR
Primers KRT6C-e7F3 (forward: 50-GTTACAGGACCCTGGTTCACTA-
30) and KRT6C-e7R3 (reverse: 50-AGGAAGTCGCGTCAGTTACCT-
30) were used with Expand High Fidelity PCR buffer (Roche)
containing 1.5mM of MgCl2, 4% DMSO and 1U Expand High
Fidelity Enzyme Mix (Roche). The following PCR conditions were
used: 94 1C for 5minutes  1, followed by 94 1C for 30 seconds,
59 1C for 45 seconds, and 72 1C for 1minute  30 and 72 1C for
5minutes  1. The resultant PCR fragment was 330 bp in size.
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Internet resources
Human Intermediate Filament Database (http://www.interfil.org)
Online Mendelian Inheritance in Man (OMIM) (http://
www.ncbi.nlm.nih.gov/omim/)
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